Mp12-18 racial Disparity in Prostate Cancer Diagnosis: A Comparison of Prostate Biopsy Results in African American and White Men Using an Mri-Based Biopsy Strategy.

Abstract

e 4.38); lung: þ2.41% (95%CI: 2.40 e 2.43); and prostate: þ4.25% (95%CI: 4.24 e 4.27)). This represents 5,322 additional minority patients accessing definitive.CONCLUSIONS: We found that patients treated at MSH for breast, colon, NSLSC, and prostate cancer are significantly less likely to receive definitive treatment for their treatment-eligible disease compared to patients treated at non-MSHs. Equalizing facility-level access to definitive cancer treatment between MSHs and non-MSHs would reduce patient-level national racial/ethnic disparities.